Evaluation of Third-line cART Regimen in Cambodia (3DICAM)

NCT03602690 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

54

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV/AIDS

Interventions

DRUG: Dolutegravir + Darunavir/ritonavir + optimized NRTI

Sponsor

ANRS, Emerging Infectious Diseases